03-11062. National Human Genome Research Institute; Notice of Closed Meetings  

  • Start Preamble

    Pursuant to section 10(d) of the Federal Advisory Committee, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

    The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Inherited Disease Research Access Committee, Group A.

    Date: May 1, 2003.

    Time: 8:30 a.m. to 3 p.m.

    Agenda: To review and evaluate grant applications.

    Place: The River Inn, 924 25th Street, Washington, DC 20037.

    Contact Person: Jerry Roberts, PHD, Scientific Review Administrator, Office of Scientific Review, National Institutes of Health, Building 38A, Bethesda, MD 20892. 301 402-0838.

    This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.

    Name of Committee: Center for Inherited Disease Research Access Committee, Group B.

    Date: May 1, 2003.

    Time: 3 p.m. to 5 p.m.

    Agenda: To review and evaluate grant applications.

    Place: The River Inn, Washington, DC 20037.

    Contact Person: Rudy O. Pozzatti, PHD, Scientific Review Administrator, Office of Scientific Review, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892. 301 402-0838.

    This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.

    Start Signature

    (Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human Genome Research, National Institutes of Health, HHS)

    Dated: April 25, 2003.

    LaVerne Y. Stringfield,

    Director, Office of Federal Advisory Committee Policy.

    End Signature End Preamble

    [FR Doc. 03-11062 Filed 5-5-03; 8:45 am]

    BILLING CODE 4140-01-M

Document Information

Effective Date:
5/1/2003
Published:
05/06/2003
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
03-11062
Dates:
May 1, 2003.
Pages:
24008-24008 (1 pages)
PDF File:
03-11062.pdf